SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326110-23-000028
Filing Date
2023-03-31
Accepted
2023-03-31 16:29:56
Documents
13
Period of Report
2023-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibrx-20230331.htm   iXBRL 8-K 34619
2 EX-10.1 ibrx-20233318xkexhibit101.htm EX-10.1 56024
  Complete submission text file 0001326110-23-000028.txt   232208

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20230331.xsd EX-101.SCH 1924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20230331_lab.xml EX-101.LAB 24128
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20230331_pre.xml EX-101.PRE 12526
7 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20230331_htm.xml XML 4109
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 23788225
SIC: 2836 Biological Products, (No Diagnostic Substances)